Latest Institutional Placement News

Beetaloo Energy has pushed construction of its Carpentaria Gas Plant forward, maintaining schedule and budget for Q4 2026 commissioning, while its Carpentaria-5H well delivers steady gas flow with low decline rates.

Barton Gold’s June quarter report highlights exceptional high-grade gold and silver assay results across its South Australian projects, backed by a $26 million institutional placement that strengthens its cash position and development outlook.

ImpediMed reported a 3% revenue increase to $3.6 million in Q4 FY26, bolstered by a $15.3 million capital raise and strategic leadership hires as it pushes growth in cancer survivorship, heart health, and weight management.

Elevra Lithium’s North American Lithium operation hit a new monthly spodumene concentrate production record in May 2026 while closing a US$298 million financing package to fund expansion and project development.

Echo IQ has locked in a strategic $20 million investment and US partnership with Pro Medicus, alongside a $110 million capital raise, positioning the company for accelerated commercial expansion of its AI-driven cardiovascular diagnostics in the US.

Syntara secured positive FDA feedback for its Phase 2b amsulostat trial in myelofibrosis and raised $8 million to extend its cash runway to Q3 2027, while preliminary data showed promising brain inflammation reduction in a Parkinson’s-related disorder.

Breakthrough Minerals has delivered promising assay results from its maiden drilling at Barbara, underpinning resource growth potential, while launching a new drilling campaign at Hazel Creek and securing A$5.15 million to fund an expanded exploration push.

Investigator Silver has moved the Paris Silver Project decisively from study to execution, bolstered by a strong cash position and key executive hires to drive development and financing.

Adisyn has confirmed a repeatable, industrial-scale graphene deposition process compatible with semiconductor manufacturing temperatures, while advancing exclusive radar absorption technology for drones with major partners.

Wrkr Ltd has completed a $10 million placement and launched a $2 million Share Purchase Plan to fund accelerated employer onboarding and platform enhancements ahead of Payday Super’s phased rollout.

CONNEQT Health's June quarter saw record consumer revenue growth and a 70% jump in enterprise subscription ARR, supported by a $5.5 million placement and progress on its FDA regulatory pathway for its cloud-based vascular analytics platform.

Recce Pharmaceuticals secured a non-binding term sheet with a major Middle Eastern pharma for its diabetic foot infection treatment and raised A$4 million to fund pivotal Phase 3 trials in Australia and Indonesia.